Literature DB >> 32303833

Successful treatment of hemorrhagic brainstem cavernous malformation with hematoma evacuation and postoperative propranolol.

Jessa E Hoffman1,2, Megan Ryan3,4, Blake Wittenberg5, Jennifer Armstrong6, Krista Greenan5,3, Corbett Wilkinson5,3.   

Abstract

In this case, we describe an evident hemorrhagic brainstem cavernous malformation successfully treated with a planned sequence of surgical evacuation of the hematoma followed by postoperative propranolol therapy. In contrast to common practice, the cavernoma itself was not resected. A nearly 3-year-old male presented with altered mental status, gait disturbance, and facial palsy. CT and MRI demonstrated a large acute pontine hematoma. A large nearby vein suggested cavernous malformation. He was initially treated conservatively but a repeat CT scan demonstrated further expansion of hematoma and he was taken emergently to the OR. Due to the sensitive location of the hematoma in the pons, we planned to evacuate the hematoma without resecting any of the presumed cavernoma. Instead, we planned to treat the cavernoma with propranolol. Postoperatively, the patient's condition improved and was still improving at hospital discharge 2 weeks later. Six-month follow-up MRI showed no cavernoma with only hemosiderin at the site of the evacuated hematoma. This is the first reported case of a hemorrhagic brainstem cavernous malformation treated with a planned sequence of hematoma evacuation followed by propranolol without an attempt to resect the cavernoma.

Entities:  

Keywords:  Cavernoma; Cavernous malformation; Propranolol

Mesh:

Substances:

Year:  2020        PMID: 32303833     DOI: 10.1007/s00381-020-04588-5

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  3 in total

1.  A 5-year outcome of propranolol for the treatment of paediatric intracranial cavernoma: case report and a review of the literature.

Authors:  Jakov Tiefenbach; Jay J Park; Chandrasekaran Kaliaperumal
Journal:  Childs Nerv Syst       Date:  2022-07-14       Impact factor: 1.532

Review 2.  Tailored Treatment Options for Cerebral Cavernous Malformations.

Authors:  Jessa E Hoffman; Blake Wittenberg; Brent Morel; Zach Folzenlogen; David Case; Christopher Roark; Samy Youssef; Joshua Seinfeld
Journal:  J Pers Med       Date:  2022-05-20

Review 3.  Cerebral Cavernous Malformation Pathogenesis: Investigating Lesion Formation and Progression with Animal Models.

Authors:  Chelsea M Phillips; Svetlana M Stamatovic; Richard F Keep; Anuska V Andjelkovic
Journal:  Int J Mol Sci       Date:  2022-04-30       Impact factor: 6.208

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.